Bio-Rad Laboratories (BIO)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$386.11-0.46%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · BIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 2,589.3 | 2,583.2 | 2,566.5 | 2,671.2 | 2,802.2 | 2,922.5 | 2,545.6 | 2,311.7 | 2,289.4 | 2,160.2 | 2,068.2 | 2,019.4 | 2,175.0 | 2,132.7 | 2,069.2 | 2,073.5 | 1,927.1 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 2,160.2 | 2,068.2 | 2,019.4 | 2,175.0 | 2,132.7 | 2,069.2 | 2,073.5 | 1,927.1 |
| Cost of Revenues | 1,245.5 | 1,243.3 | 1,187.6 | 1,244.3 | 1,234.9 | 1,284.4 | 1,107.7 | 1,054.7 | 1,066.3 | — | — | — | — | — | — | — | — |
| Gross Profit | 1,343.8 | 1,339.9 | 1,378.9 | 1,426.9 | 1,567.3 | 1,638.1 | 1,437.9 | 1,257.0 | 1,223.2 | 1,187.7 | 1,138.4 | 1,121.7 | 1,178.5 | 1,178.5 | 1,155.2 | 1,178.8 | 1,091.5 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 852.2 | 844.3 | 814.0 | 841.7 | 827.8 | 877.1 | 798.8 | 824.6 | 834.8 | 806.8 | 814.7 | 762.0 | 808.2 | 798.1 | 681.8 | 696.0 | 635.2 |
| R&D Expenses | 265.7 | 275.6 | 295.9 | 247.4 | 256.9 | 260.6 | 217.8 | 202.7 | 199.2 | 250.2 | 205.7 | 193.0 | 220.3 | 211.0 | 209.2 | 177.6 | 172.3 |
| Operating Income | 53.1 | 47.2 | 269.0 | 337.8 | 482.6 | 500.3 | 421.3 | 229.7 | (103.3) | 119.3 | 55.7 | 166.7 | 150.0 | 169.5 | 264.2 | 305.2 | 284.0 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | 48.8 | 49.0 | 48.9 | 49.4 | 38.1 | 1.6 | 21.9 | 23.4 | 24.0 | 23.0 | 23.4 | 21.7 | 22.1 | 61.3 | 51.1 | 53.1 | 63.7 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | 0.0 | — | — | — | — | — | — |
| Asset Writedown | — | 172.8 | — | 0.0 | — | — | 0.0 | 0.0 | 292.5 | 11.5 | 62.3 | — | — | — | — | 0.0 | 3.8 |
| EBT, Incl. Unusual Items | 350.4 | 995.5 | (2,342.5) | (850.1) | (4,704.2) | 5,449.1 | 4,907.6 | 2,261.1 | 512.7 | 97.8 | 41.6 | 145.8 | 131.6 | 112.4 | 229.9 | 245.8 | 220.3 |
| Income Tax Expense | 128.0 | 235.6 | (498.3) | (212.8) | (1,076.7) | 1,194.8 | 1,103.8 | 502.4 | 147.0 | (24.4) | 15.6 | 36.6 | 42.7 | 34.6 | 64.4 | 67.0 | 33.3 |
| Net Income | |||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.1 | (0.2) | 1.4 |
| Net Income | 222.4 | 759.9 | (1,844.2) | (637.3) | (3,627.5) | 4,254.3 | 3,814.2 | 1,758.7 | 365.6 | 122.2 | 26.0 | 109.2 | 88.8 | 77.8 | 165.5 | 179.0 | 185.5 |
| Per Share | |||||||||||||||||
| Basic EPS | 8.32 | 27.87 | (65.36) | (21.82) | (121.79) | 142.61 | 128.13 | 58.93 | 12.25 | 4.12 | 0.88 | 3.74 | 3.08 | 2.72 | 5.85 | 6.39 | 6.70 |
| Diluted EPS | 8.29 | 27.85 | — | (21.82) | (121.79) | 140.83 | 126.47 | 58.27 | 12.10 | 4.07 | 0.88 | 3.71 | 3.05 | 2.69 | 5.78 | 6.29 | 6.59 |
| Revenue per Share | 96.57 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 26.7 | 27.3 | 28.2 | 29.2 | 29.8 | 29.8 | 29.8 | 29.8 | 29.8 | 29.7 | 29.4 | 29.2 | 28.9 | 28.6 | 28.3 | 28.0 | 27.7 |
| Diluted Weighted Avg Shares | 26.8 | 27.3 | 28.2 | 29.2 | 29.8 | 30.2 | 30.2 | 30.2 | 30.2 | 30.0 | 29.6 | 29.4 | 29.1 | 28.9 | 28.6 | 28.5 | 28.2 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 212.6 | 420.6 | 483.7 | 619.9 | 637.9 | 559.9 | 363.9 | 34.8 | 268.0 | 198.6 | 298.5 | 299.9 | 316.7 | 394.6 | 426.2 | — |
| EBIT | 53.1 | 47.2 | 269.0 | 337.8 | 482.6 | 500.3 | 421.3 | 229.7 | (103.3) | 119.3 | 55.7 | 166.7 | 150.0 | 169.5 | 264.2 | 305.2 | 284.0 |
| Effective Tax Rate | 36.5% | — | — | 25.0% | 22.9% | 21.9% | 22.5% | 22.2% | 28.7% | -25.0% | 37.4% | 25.1% | 32.5% | 30.8% | 28.0% | 27.3% | 15.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.